These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2675017)

  • 21. Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.
    Rinehart J; Malspeis L; Young D; Neidhart J
    Cancer Res; 1986 Oct; 46(10):5364-7. PubMed ID: 3756886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute right ventricular heart failure in a patient with renal cell carcinoma after interferon therapy.
    Kramers C; de Mulder PH; Barth JD; Wagener DJ
    Neth J Med; 1993 Feb; 42(1-2):65-8. PubMed ID: 8446228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of recombinant interferon alfa on bone metastases of renal-cell carcinoma.
    Fosså SD; Lien HH; Lindegaard M
    N Engl J Med; 1991 Feb; 324(9):633-4. PubMed ID: 1992326
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case in which alpha-interferon showed remarkable effect against the brain, bone, and lung metastases arising from the renal cell carcinoma].
    Tanaka J; Takita T; Murase T; Shimoji T; Miyake K; Mitsuya H
    Hinyokika Kiyo; 1986 Feb; 32(2):241-8. PubMed ID: 3728231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects.
    Budd GT; Osgood B; Barna B; Boyett JM; Finke J; Medendorp SV; Murthy S; Novak C; Sergi J; Tubbs R
    Cancer Res; 1989 Nov; 49(22):6432-6. PubMed ID: 2804986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma.
    Quesada JR; Evans L; Saks SR; Gutterman JU
    J Biol Response Mod; 1988 Jun; 7(3):234-9. PubMed ID: 3134511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of metastatic renal cell carcinoma with human lymphoblastoid interferon].
    Ryu S; Fukuoka M; Tamai S; Takifuji N; Sakai N; Matsui K; Negoro S; Takada M; Kusunoki Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):996-1002. PubMed ID: 3694004
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
    Vugrin D; Hood L; Taylor W; Laszlo J
    Cancer Treat Rep; 1985; 69(7-8):817-20. PubMed ID: 4016792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy and metastic renal cell cancer.
    Buzio C; De Palma G; Caminiti C; Cattabiani MA; Manenti L
    Nephrol Dial Transplant; 1996 Sep; 11(9):1890. PubMed ID: 8918650
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical studies on interferon in cancer therapy in Japan].
    Ohno R
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1194-202. PubMed ID: 2437862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A combined treatment of interferon-alpha, 8 MHz radiofrequency hyperthermia and/or irradiation in a patient with advanced renal cancer].
    Nakajima K; Hisazumi H; Nakashima T; Yokoyama O; Nagano K; Kobashi K; Naito K; Misaki T; Saito Y; Takashima T
    Hinyokika Kiyo; 1987 Nov; 33(11):1851-6. PubMed ID: 3445869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
    Kirkwood JM; Harris JE; Vera R; Sandler S; Fischer DS; Khandekar J; Ernstoff MS; Gordon L; Lutes R; Bonomi P
    Cancer Res; 1985 Feb; 45(2):863-71. PubMed ID: 3881175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Various questions concerning the treatment of renal cell carcinoma].
    Ueda T
    Fukuoka Igaku Zasshi; 1990 Jan; 81(1):1-4. PubMed ID: 2108916
    [No Abstract]   [Full Text] [Related]  

  • 34. [Sequential combination therapy with alpha interferon and OK-432 (streptococcal preparation) against advanced renal cell carcinoma].
    Marumo K; Mura M; Deguchi N; Baba S; Jitsukawa S; Nakazono M; Tazaki H
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2434-9. PubMed ID: 3729498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of complete resolution of multiple metastases of advanced renal cell carcinoma following partial jejunotomy in intestinal metastases and interferon therapy].
    Miyata M; Watabe Y; Okamura K; Fujisawa M; Arima S; Yachiku S
    Hinyokika Kiyo; 1988 Oct; 34(10):1783-8. PubMed ID: 3245527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phase II study of recombinant human interferon gamma (S-6810) in renal cell carcinoma. Urological Cooperative Study Group of Recombinant Human Interferon Gamma (S-6810)].
    Machida T; Koiso K; Takaku F; Ogawa M
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):440-5. PubMed ID: 3101607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A study of the clinical response of renal cell carcinoma to human lymphoblastoid interferon (MOR-22)].
    Niijima T
    Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1277-84. PubMed ID: 3782978
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II trial of recombinant interferon alpha-2C in metastatic renal cell carcinoma.
    Scheithauer W; Kuehrer I; Kutzmits R; Dittrich C; Steger G; Flener R; Ludwig H
    J Biol Regul Homeost Agents; 1987; 1(2):81-6. PubMed ID: 3504086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe.
    Negrier S; Maral J; Drevon M; Vinke J; Escudier B; Philip T
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S93-8. PubMed ID: 10685667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interferon-alpha therapy for hairy cell leukemia and lymphoproliferative disorders simulating hairy cell leukemia (hairy cell leukemia variant): a cooperative group study in Japan].
    Machii T; Kitani T; Kimura K; Maekawa I; Matsuzaki M; Mikuni C; Niikawa K; Igarashi T; Abe T; Miura Y
    Rinsho Ketsueki; 1988 Nov; 29(11):2029-36. PubMed ID: 3070073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.